Literature DB >> 23027528

Bordetella parapertussis survives the innate interaction with human neutrophils by impairing bactericidal trafficking inside the cell through a lipid raft-dependent mechanism mediated by the lipopolysaccharide O antigen.

Juan Gorgojo1, Yanina Lamberti, Hugo Valdez, Eric T Harvill, Maria Eugenia Rodríguez.   

Abstract

Whooping cough is a reemerging disease caused by two closely related pathogens, Bordetella pertussis and Bordetella parapertussis. The incidence of B. parapertussis in whooping cough cases has been increasing since the introduction of acellular pertussis vaccines containing purified antigens that are common to both strains. Recently published results demonstrated that these vaccines do not protect against B. parapertussis due to the presence of the O antigen on the bacterial surface that impairs antibody access to shared antigens. We have investigated the effect of the lack of opsonization of B. parapertussis on the outcome of its interaction with human neutrophils (polymorphonuclear leukocytes [PMNs]). In the absence of opsonic antibodies, PMN interaction with B. parapertussis resulted in nonbactericidal trafficking upon phagocytosis. A high percentage of nonopsonized B. parapertussis was found in nonacidic lysosome marker (lysosome-associated membrane protein [LAMP])-negative phagosomes with access to the host cell-recycling pathway of external nutrients, allowing bacterial survival as determined by intracellular CFU counts. The lipopolysaccharide (LPS) O antigen was found to be involved in directing B. parapertussis to PMN lipid rafts, eventually determining the nonbactericidal fate inside the PMN. IgG opsonization of B. parapertussis drastically changed this interaction by not only inducing efficient PMN phagocytosis but also promoting PMN bacterial killing. These data provide new insights into the immune mechanisms of hosts against B. parapertussis and document the crucial importance of opsonic antibodies in immunity to this pathogen.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23027528      PMCID: PMC3497435          DOI: 10.1128/IAI.00662-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Effect of temperature modulation and bvg mutation of Bordetella bronchiseptica on adhesion, intracellular survival and cytotoxicity for swine alveolar macrophages.

Authors:  S L Brockmeier; K B Register
Journal:  Vet Microbiol       Date:  2000-04-04       Impact factor: 3.293

2.  Fc receptor-mediated immunity against Bordetella pertussis.

Authors:  M E Rodriguez; S M Hellwig; D F Hozbor; J Leusen; W L van der Pol; J G van de Winkel
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

Review 3.  Pathogens: raft hijackers.

Authors:  Santos Mañes; Gustavo del Real; Carlos Martínez-A
Journal:  Nat Rev Immunol       Date:  2003-07       Impact factor: 53.106

4.  Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica.

Authors:  Julian Parkhill; Mohammed Sebaihia; Andrew Preston; Lee D Murphy; Nicholas Thomson; David E Harris; Matthew T G Holden; Carol M Churcher; Stephen D Bentley; Karen L Mungall; Ana M Cerdeño-Tárraga; Louise Temple; Keith James; Barbara Harris; Michael A Quail; Mark Achtman; Rebecca Atkin; Steven Baker; David Basham; Nathalie Bason; Inna Cherevach; Tracey Chillingworth; Matthew Collins; Anne Cronin; Paul Davis; Jonathan Doggett; Theresa Feltwell; Arlette Goble; Nancy Hamlin; Heidi Hauser; Simon Holroyd; Kay Jagels; Sampsa Leather; Sharon Moule; Halina Norberczak; Susan O'Neil; Doug Ormond; Claire Price; Ester Rabbinowitsch; Simon Rutter; Mandy Sanders; David Saunders; Katherine Seeger; Sarah Sharp; Mark Simmonds; Jason Skelton; Robert Squares; Steven Squares; Kim Stevens; Louise Unwin; Sally Whitehead; Bart G Barrell; Duncan J Maskell
Journal:  Nat Genet       Date:  2003-08-10       Impact factor: 38.330

5.  The 2001 serological survey in the Czech Republic--parapertussis.

Authors:  M Maixnerová
Journal:  Cent Eur J Public Health       Date:  2003-12       Impact factor: 1.163

6.  Patterns of Bordetella parapertussis respiratory illnesses: 2008-2010.

Authors:  James D Cherry; Brent L Seaton
Journal:  Clin Infect Dis       Date:  2011-12-07       Impact factor: 9.079

7.  Role of the Brucella suis lipopolysaccharide O antigen in phagosomal genesis and in inhibition of phagosome-lysosome fusion in murine macrophages.

Authors:  Françoise Porte; Aroem Naroeni; Safia Ouahrani-Bettache; Jean-Pierre Liautard
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

8.  Clinical and epidemiological picture of B pertussis and B parapertussis infections after introduction of acellular pertussis vaccines.

Authors:  J G Liese; C Renner; S Stojanov; B H Belohradsky
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

9.  Role of Bordetella O antigen in respiratory tract infection.

Authors:  Valorie C Burns; Elizabeth J Pishko; Andrew Preston; Duncan J Maskell; Eric T Harvill
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  Efficacies of whole cell and acellular pertussis vaccines against Bordetella parapertussis in a mouse model.

Authors:  Silke David; Ralph van Furth; Frits R Mooi
Journal:  Vaccine       Date:  2004-05-07       Impact factor: 3.641

View more
  9 in total

1.  Bordetella parapertussis survives inside human macrophages in lipid raft-enriched phagosomes.

Authors:  Juan Gorgojo; Eric T Harvill; Maria Eugenia Rodríguez
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

Review 2.  Intracellular signalling pathways: targets to reverse immunosenescence.

Authors:  T Fulop; J M Witkowski; A Le Page; C Fortin; G Pawelec; A Larbi
Journal:  Clin Exp Immunol       Date:  2016-08-03       Impact factor: 4.330

Review 3.  Lipopolysaccharide O-antigens-bacterial glycans made to measure.

Authors:  Chris Whitfield; Danielle M Williams; Steven D Kelly
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

4.  Type Six Secretion System of Bordetella bronchiseptica and Adaptive Immune Components Limit Intracellular Survival During Infection.

Authors:  Liron Bendor; Laura S Weyrich; Bodo Linz; Olivier Y Rolin; Dawn L Taylor; Laura L Goodfield; William E Smallridge; Mary J Kennett; Eric T Harvill
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

5.  Bordetella parapertussis Circumvents Neutrophil Extracellular Bactericidal Mechanisms.

Authors:  Juan Gorgojo; Emilia Scharrig; Ricardo M Gómez; Eric T Harvill; Maria Eugenia Rodríguez
Journal:  PLoS One       Date:  2017-01-17       Impact factor: 3.240

6.  Conservation of Ancient Genetic Pathways for Intracellular Persistence Among Animal Pathogenic Bordetellae.

Authors:  Israel Rivera; Bodo Linz; Kalyan K Dewan; Longhuan Ma; Christopher A Rice; Dennis E Kyle; Eric T Harvill
Journal:  Front Microbiol       Date:  2019-12-11       Impact factor: 5.640

7.  Melanin Produced by Bordetella parapertussis Confers a Survival Advantage to the Bacterium during Host Infection.

Authors:  Yukihiro Hiramatsu; Takashi Nishida; Dendi Krisna Nugraha; Fuminori Sugihara; Yasuhiko Horiguchi
Journal:  mSphere       Date:  2021-10-13       Impact factor: 4.389

8.  Enhancement of immune response against Bordetella spp. by disrupting immunomodulation.

Authors:  Monica C Gestal; Laura K Howard; Kalyan Dewan; Hannah M Johnson; Mariette Barbier; Clare Bryant; Illiassou Hamidou Soumana; Israel Rivera; Bodo Linz; Uriel Blas-Machado; Eric T Harvill
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

Review 9.  Evolution and Conservation of Bordetella Intracellular Survival in Eukaryotic Host Cells.

Authors:  Israel Rivera; Bodo Linz; Eric T Harvill
Journal:  Front Microbiol       Date:  2020-10-15       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.